Cargando…

Prevalence of serum N-methyl-d-aspartate receptor autoantibodies in refractory psychosis

N-methyl-d-aspartate receptor (NMDA-R) autoantibodies have been reported in people with acute psychosis. We hypothesised that their presence may be implicated in the aetiology of treatment-refractory psychosis. We sought to ascertain the point prevalence of NMDA-R antibody positivity in patients ref...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beck, Katherine, Lally, John, Shergill, Sukhwinder S., Bloomfield, Michael A. P., MacCabe, James H., Gaughran, Fiona, Howes, Oliver D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royal College of Psychiatrists 2015
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312967/ https://www.ncbi.nlm.nih.gov/pubmed/25431428 http://dx.doi.org/10.1192/bjp.bp.113.142216

Ejemplares similares

Real-world effectiveness of admissions to a tertiary treatment-resistant psychosis service: 2-year mirror-image study
por: Casetta, Cecilia, et al.
Publicado: (2020)

Outcomes in treatment-resistant schizophrenia: symptoms, function and clozapine plasma concentrations
por: Krivoy, Amir, et al.
Publicado: (2021)

Management of clozapine treatment during the COVID-19 pandemic
por: Gee, Siobhan, et al.
Publicado: (2020)

Unheard voices: outcomes of tertiary care for treatment-refractory psychosis
por: Sarkar, S. Neil, et al.
Publicado: (2014)

Unheard voices: outcomes of tertiary care for treatment-refractory psychosis — ADDENDUM
por: Sarkar, S. Neil, et al.
Publicado: (2019)

N-Methyl-D-Aspartate Receptor binding in First-Episode Psychosis: A PET brain imaging study
por: Beck, Katherine, et al.
Publicado: (2021)

Autoantibodies to the N-Methyl-D-Aspartate Receptor in Adolescents With Early Onset Psychosis and Healthy Controls
por: Engen, Kristine, et al.
Publicado: (2020)

The relationship between nicotine and psychosis
por: Quigley, Harriet, et al.
Publicado: (2019)

Does environmental confounding mask pleiotropic effects of a multiple sclerosis susceptibility variant on vitamin D in psychosis?
por: Iyegbe, Conrad O, et al.
Publicado: (2015)

Prevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review and Meta-Analysis
por: Shirazi, Ayala, et al.
Publicado: (2016)

41. RECONSIDERING THE EVIDENCE FOR CLOZAPINE FOR TREATMENT REFRACTORY SCHIZOPHRENIA
por: MacCabe, James
Publicado: (2018)

T183. LOW LEVELS OF VITAMIN D ARE ASSOCIATED WITH REDUCED CORTICAL THICKNESS AND SURFACE AREA IN FRONTAL, TEMPORAL AND OCCIPITAL REGIONS IN FIRST-EPISODE PSYCHOSIS PATIENTS
por: Ciufolini, Simone, et al.
Publicado: (2020)

Patterns of illness and care over the 5 years following onset of psychosis in different ethnic groups; the GAP-5 study
por: Ajnakina, Olesya, et al.
Publicado: (2017)

N-methyl-D-aspartate receptor availability in first-episode psychosis: a PET-MR brain imaging study
por: Beck, Katherine, et al.
Publicado: (2021)

It is time to start taking tobacco seriously as a risk factor for psychosis: self‐medication cannot explain the association
por: MacCabe, J. H.
Publicado: (2018)

N-Methyl-D-Aspartate Receptor availability in First-Episode Psychosis: a multi-modal PET-MR brain imaging study
por: Beck, K., et al.
Publicado: (2022)

Clinical correlates of vitamin D deficiency in established psychosis
por: Lally, J., et al.
Publicado: (2016)

Serum Systemic Autoantibodies in Anti-N-Methyl-D-Aspartate Receptor Encephalitis
por: Zhang, Bingjun, et al.
Publicado: (2020)

S19. EVIDENCE OF THE LIPID PARADOX IN PSYCHOSIS: A META-ANALYSIS OF CHOLESTEROL AND TRIGLYCERIDE LEVELS IN FIRST EPISODE PSYCHOSIS
por: Pillinger, Toby, et al.
Publicado: (2018)

Autoantibodies detection in anti-N-methyl-D-aspartate receptor encephalitis
por: Li, Jiayu, et al.
Publicado: (2021)

S24. IS IT FEASIBLE TO PREDICT LONG-TERM METABOLIC OUTCOMES IN PSYCHOSIS USING BIOLOGICAL PROFILING AT BASELINE?
por: Iyegbe, Conrad, et al.
Publicado: (2018)

Does tobacco use cause psychosis? Systematic review and meta-analysis
por: Gurillo, Pedro, et al.
Publicado: (2015)

Early Intervention for Psychosis with N-Methyl-D-Aspartate Receptor Modulators
por: Dong, Chao, et al.
Publicado: (2015)

Autoantibodies against N-methyl-d-aspartate receptor 1 in health and disease
por: Ehrenreich, Hannelore
Publicado: (2018)

Thyroid Autoantibody Positive Anti-N-Methyl-D-Aspartate Receptor Encephalitis
por: Jung, Yoori, et al.
Publicado: (2016)

Cognitive correlates of abnormal myelination in psychosis
por: Vanes, Lucy D., et al.
Publicado: (2019)

Lower Bone Mineral Density at the Hip and Lumbar Spine in People with Psychosis Versus Controls: a Comprehensive Review and Skeletal Site-Specific Meta-analysis
por: Gomez, Lucia, et al.
Publicado: (2016)

Virtual reality cognitive & functional assessment in psychosis
por: Shergill, Sukhwinder, et al.
Publicado: (2021)

A symptom-based approach to treatment of psychosis in autism spectrum disorder
por: Bell, Victoria, et al.
Publicado: (2018)

Relationship Between Replay-Associated Ripples and Hippocampal N-Methyl-D-Aspartate Receptors: Preliminary Evidence From a PET-MEG Study in Schizophrenia
por: Nour, Matthew M, et al.
Publicado: (2022)

Successful clozapine re-challenge in a patient with three previous episodes of clozapine-associated blood dyscrasia
por: Foster, Jessica, et al.
Publicado: (2017)

Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-d-Aspartate Receptor
por: Chang, Eric H., et al.
Publicado: (2015)

Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis
por: Pillinger, Toby, et al.
Publicado: (2017)

T19. GLUTAMATE AND RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Egerton, Alice, et al.
Publicado: (2020)

Developmental attenuation of N-methyl-D-aspartate receptor subunit expression by microRNAs
por: Corbel, Caroline, et al.
Publicado: (2015)

Catatonic features in children and adolescents with N-methyl-d-aspartate receptor antibody encephalitis
por: Eyre, Michael, et al.
Publicado: (2020)

42.1 BODY AND MIND: CARDIO-METABOLIC AND IMMUNE FUNCTION IN FIRST EPISODE PSYCHOSIS AND COMPARISON WITH CENTRAL NEUROFUNCTIONAL MEASURES
por: Howes, Oliver, et al.
Publicado: (2018)

Anti N‐Methyl‐D‐Aspartate (NMDA) receptor encephalitis: from psychosis to cognitive impairment
por: Vahabi, Zahra, et al.
Publicado: (2021)

Identification of Medium-Length Antineurofilament Autoantibodies in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis
por: Wang, Shisi, et al.
Publicado: (2020)

Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort study
por: Gaughran, Fiona, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1jj3km7bca2pmkgkhabmk7bv9k